310 related articles for article (PubMed ID: 33387156)
1. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.
Reizine F; Lesouhaitier M; Gregoire M; Pinceaux K; Gacouin A; Maamar A; Painvin B; Camus C; Le Tulzo Y; Tattevin P; Revest M; Le Bot A; Ballerie A; Cador-Rousseau B; Lederlin M; Lebouvier T; Launey Y; Latour M; Verdy C; Rossille D; Le Gallou S; Dulong J; Moreau C; Bendavid C; Roussel M; Cogne M; Tarte K; Tadié JM
J Clin Immunol; 2021 Apr; 41(3):515-525. PubMed ID: 33387156
[TBL] [Abstract][Full Text] [Related]
2. Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection.
Sacchi A; Grassi G; Notari S; Gili S; Bordoni V; Tartaglia E; Casetti R; Cimini E; Mariotti D; Garotto G; Beccacece A; Marchioni L; Bibas M; Nicastri E; Ippolito G; Agrati C
Cells; 2021 Aug; 10(8):. PubMed ID: 34440879
[TBL] [Abstract][Full Text] [Related]
3. Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience.
Mahida RY; Chotalia M; Alderman J; Patel C; Hayden A; Desai R; Beesley E; Crowley LE; Soltan M; Bangash M; Parekh D; Patel J; Thickett DR
BMJ Open Respir Res; 2020 Nov; 7(1):. PubMed ID: 33257441
[TBL] [Abstract][Full Text] [Related]
4. Effect of early treatment with polyvalent immunoglobulin on acute respiratory distress syndrome associated with SARS-CoV-2 infections (ICAR trial): study protocol for a randomized controlled trial.
Mazeraud A; Gonçalves B; Aegerter P; Mancusi L; Rieu C; Bozza F; Sylla K; Siami S; Sharshar T
Trials; 2021 Feb; 22(1):170. PubMed ID: 33648563
[TBL] [Abstract][Full Text] [Related]
5. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.
Weiskopf D; Schmitz KS; Raadsen MP; Grifoni A; Okba NMA; Endeman H; van den Akker JPC; Molenkamp R; Koopmans MPG; van Gorp ECM; Haagmans BL; de Swart RL; Sette A; de Vries RD
Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32591408
[TBL] [Abstract][Full Text] [Related]
6. Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells.
Dean MJ; Ochoa JB; Sanchez-Pino MD; Zabaleta J; Garai J; Del Valle L; Wyczechowska D; Baiamonte LB; Philbrook P; Majumder R; Vander Heide RS; Dunkenberger L; Thylur RP; Nossaman B; Roberts WM; Chapple AG; Wu J; Hicks C; Collins J; Luke B; Johnson R; Koul HK; Rees CA; Morris CR; Garcia-Diaz J; Ochoa AC
Front Immunol; 2021; 12():695972. PubMed ID: 34341659
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Risk Factors of Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients in Beijing, China: A Retrospective Study.
Wang A; Gao G; Wang S; Chen M; Qian F; Tang W; Xu Y; Song R; Zhuang L; Ma X; Zhao T; Guo X; Li W; Wang X; Li B; Hu C; Chen Z; Zhang F
Med Sci Monit; 2020 Sep; 26():e925974. PubMed ID: 32973126
[TBL] [Abstract][Full Text] [Related]
8. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome.
Sacchi A; Grassi G; Bordoni V; Lorenzini P; Cimini E; Casetti R; Tartaglia E; Marchioni L; Petrosillo N; Palmieri F; D'Offizi G; Notari S; Tempestilli M; Capobianchi MR; Nicastri E; Maeurer M; Zumla A; Locatelli F; Antinori A; Ippolito G; Agrati C
Cell Death Dis; 2020 Oct; 11(10):921. PubMed ID: 33110074
[TBL] [Abstract][Full Text] [Related]
9. Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome.
Hue S; Beldi-Ferchiou A; Bendib I; Surenaud M; Fourati S; Frapard T; Rivoal S; Razazi K; Carteaux G; Delfau-Larue MH; Mekontso-Dessap A; Audureau E; de Prost N
Am J Respir Crit Care Med; 2020 Dec; 202(11):1509-1519. PubMed ID: 32866033
[No Abstract] [Full Text] [Related]
10. Comparative immune profiling of acute respiratory distress syndrome patients with or without SARS-CoV-2 infection.
Roussel M; Ferrant J; Reizine F; Le Gallou S; Dulong J; Carl S; Lesouhaitier M; Gregoire M; Bescher N; Verdy C; Latour M; Bézier I; Cornic M; Vinit A; Monvoisin C; Sawitzki B; Leonard S; Paul S; Feuillard J; Jeannet R; Daix T; Tiwari VK; Tadié JM; Cogné M; Tarte K
Cell Rep Med; 2021 Jun; 2(6):100291. PubMed ID: 33977279
[TBL] [Abstract][Full Text] [Related]
11. Myeloid-derived suppressor cells and T cell populations in children with Multisystem Inflammatory Syndrome.
Bline KE; Wilt AL; Alexander RN; Andrews AN; Mertz SE; Ye F; Steele LM; Wolfe AL; Mejias A; Ramilo O
Pediatr Res; 2024 Apr; 95(5):1288-1294. PubMed ID: 38042945
[TBL] [Abstract][Full Text] [Related]
12. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
13. The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic.
Baker D; Amor S; Kang AS; Schmierer K; Giovannoni G
Mult Scler Relat Disord; 2020 Aug; 43():102174. PubMed ID: 32464584
[TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay.
Galassi G; Marchioni A
Acta Neurol Belg; 2021 Jun; 121(3):633-642. PubMed ID: 33811309
[TBL] [Abstract][Full Text] [Related]
15. Acquired agitation in acute respiratory distress syndrome with COVID-19 compared to influenza patients: a propensity score matching observational study.
Maamar A; Liard C; Doucet W; Reizine F; Painvin B; Delamaire F; Coirier V; Quelven Q; Guillot P; Lesouhaitier M; Tadié JM; Gacouin A
Virol J; 2022 Sep; 19(1):145. PubMed ID: 36085163
[TBL] [Abstract][Full Text] [Related]
16. Prolonged prothrombin time as an early prognostic indicator of severe acute respiratory distress syndrome in patients with COVID-19 related pneumonia.
Baranovskii DS; Klabukov ID; Krasilnikova OA; Nikogosov DA; Polekhina NV; Baranovskaia DR; Laberko LA
Curr Med Res Opin; 2021 Jan; 37(1):21-25. PubMed ID: 33210948
[TBL] [Abstract][Full Text] [Related]
17. Prolonged Intermittent Renal Replacement Therapy for Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome.
Ramirez-Sandoval JC; Gaytan-Arocha JE; Xolalpa-Chávez P; Mejia-Vilet JM; Arvizu-Hernandez M; Rivero-Sigarroa E; Torruco-Sotelo C; Correa-Rotter R; Vega-Vega O
Blood Purif; 2021; 50(3):355-363. PubMed ID: 33105136
[TBL] [Abstract][Full Text] [Related]
18. Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: A pilot study.
Monreal E; Maza S S; Gullón P; Natera-Villalba E; Chico-García JL; Beltrán-Corbellini Á; Martínez-Sanz J; García-Barragán N; Buisán J; Toledano R; Alonso-Canovas A; Pérez-Torre P; Matute-Lozano MC; López-Sendón JL; García-Ribas G; Corral Í; Fortún J; Montero-Errasquín B; Manzano L; Máiz-Carro L; Costa-Frossard L; Masjuan J;
J Med Virol; 2021 Apr; 93(4):2243-2251. PubMed ID: 33165922
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series.
Hashemian SR; Aliannejad R; Zarrabi M; Soleimani M; Vosough M; Hosseini SE; Hossieni H; Keshel SH; Naderpour Z; Hajizadeh-Saffar E; Shajareh E; Jamaati H; Soufi-Zomorrod M; Khavandgar N; Alemi H; Karimi A; Pak N; Rouzbahani NH; Nouri M; Sorouri M; Kashani L; Madani H; Aghdami N; Vasei M; Baharvand H
Stem Cell Res Ther; 2021 Jan; 12(1):91. PubMed ID: 33514427
[TBL] [Abstract][Full Text] [Related]
20. High Levels of Neutrophil Extracellular Traps Persist in the Lower Respiratory Tract of Critically Ill Patients With Coronavirus Disease 2019.
Ouwendijk WJD; Raadsen MP; van Kampen JJA; Verdijk RM; von der Thusen JH; Guo L; Hoek RAS; van den Akker JPC; Endeman H; Langerak T; Molenkamp R; Gommers D; Koopmans MPG; van Gorp ECM; Verjans GMGM; Haagmans BL
J Infect Dis; 2021 May; 223(9):1512-1521. PubMed ID: 33507309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
